The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1235-1244.e58 , December 2009

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis

  • Emma Guttman-Yassky, MD, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
    • Department of Dermatology, Weill-Cornell Medical College, Cornell University, New York, NY
    • These authors contributed equally to this work.
  • ,
  • Mayte Suárez-Fariñas, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
    • These authors contributed equally to this work.
  • ,
  • Andrea Chiricozzi, MD

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
    • Department of Dermatology, University of Rome “Tor Vergata”, Rome, Italy
  • ,
  • Kristine E. Nograles, MD

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
  • ,
  • Avner Shemer, MD

      Affiliations

    • Tel-Hashomer Hospital and Tel-Aviv University, Tel-Aviv, Israel
  • ,
  • Judilyn Fuentes-Duculan, MD

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
  • ,
  • Irma Cardinale, MSc

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
  • ,
  • Peng Lin, BSc

      Affiliations

    • Department of Genetics, Washington University School of Medicine, St Louis, Mo
  • ,
  • Reuven Bergman, MD

      Affiliations

    • Rambam Medical Center and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
  • ,
  • Anne M. Bowcock, PhD

      Affiliations

    • Department of Genetics, Washington University School of Medicine, St Louis, Mo
  • ,
  • James G. Krueger, MD, PhD

      Affiliations

    • Laboratory for Investigative Dermatology, Rockefeller University, New York, NY
    • Corresponding Author InformationReprint requests: James G. Krueger, MD, PhD, Laboratory for Investigative Dermatology, Rockefeller University, 1230 York Avenue, New York, NY 10065.

Received 4 August 2009 ,Revised 15 September 2009 ,Accepted 17 September 2009.

  • Image Result

    Genomic expression differences between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated (A) and downregulated (B) genes in PS and top 25 upregulated (C) a

    Genomic expression differences between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated (A) and downregulated (B) genes in PS and top 25 upregulated (C) and downregulated (D) genes in AD. FC values represent AD and PS versus normal skin; FDR <0.001.

  • Image Result
    Genomic expression differences between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated (A) and downregulated (B) genes in PS and top 25 upregulated (C) a

    Genomic expression differences between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated (A) and downregulated (B) genes in PS and top 25 upregulated (C) and downregulated (D) genes in AD. FC values represent AD and PS versus normal skin; FDR <0.001.

  • Image Result
    Genomic expression of terminal differentiation (CE and EDC) genes. A, Downregulation of terminal differentiation genes in AD compared with normal and psoriasis (PS) skin. FC by microarrays in log2 sca

    Genomic expression of terminal differentiation (CE and EDC) genes. A, Downregulation of terminal differentiation genes in AD compared with normal and psoriasis (PS) skin. FC by microarrays in log2 scale, FDR <0.05. B, Real-time PCR analysis showing significant downregulation of LCE1, LCE2, CDSN, and SPRR2C in AD; P <.05; ∗∗P <.01; ∗∗∗P <.001. C, Terminal differentiation class prediction, discriminating AD and PS. Horizontal bars represent centroids for the AD and PS groups (upregulated genes [vs normal] on the right and downregulated on the left). Norm, Normal.

  • Image Result
    Genomic expression of terminal differentiation (CE and EDC) genes. A, Downregulation of terminal differentiation genes in AD compared with normal and psoriasis (PS) skin. FC by microarrays in log2 sca

    Genomic expression of terminal differentiation (CE and EDC) genes. A, Downregulation of terminal differentiation genes in AD compared with normal and psoriasis (PS) skin. FC by microarrays in log2 scale, FDR <0.05. B, Real-time PCR analysis showing significant downregulation of LCE1, LCE2, CDSN, and SPRR2C in AD; P <.05; ∗∗P <.01; ∗∗∗P <.001. C, Terminal differentiation class prediction, discriminating AD and PS. Horizontal bars represent centroids for the AD and PS groups (upregulated genes [vs normal] on the right and downregulated on the left). Norm, Normal.

  • Image Result
    Compromised epidermal barrier integrity in AD versus normal skin. SC of a healthy volunteer (A and E) and a representative patient with AD patient (B-D, F). Nile red fluorescence in normal (G) and AD

    Compromised epidermal barrier integrity in AD versus normal skin. SC of a healthy volunteer (A and E) and a representative patient with AD patient (B-D, F). Nile red fluorescence in normal (G) and AD SC (H). CE (white arrows), corneodesmosomes (black arrows), lamellar body (white asterisk), and keratin filaments (white triangles). Disruption of CE, degradion of corneodesmosomes (B-D), increased corneocyte thickness, and decreased compaction of keratin filaments in AD (F) compared with normal skin (E). Decreased corneocyte compaction and reduced intercellular lipids in AD (H) versus normal skin (G). Scale bars: A-D, 500 nm; E and F, 5 um; G and H, × 40 magnification, zoom × 9.7.

  • Image Result
    Characterization of major terminal differentiation proteins in normal skin, psoriasis (PS), and AD by immunohistochemistry. Skin sections were stained for hyperplasia (K16) (A) and the following: FLG

    Characterization of major terminal differentiation proteins in normal skin, psoriasis (PS), and AD by immunohistochemistry. Skin sections were stained for hyperplasia (K16) (A) and the following: FLG (B), IVL (C), CDSN (D), and LOR (E). Although PS and AD showed similar acanthosis (A), delayed expression and abnormal formation of differentiation proteins characterized AD.

  • Image Result
    Differentially and commonly upregulated (red) and downregulated (green) regulated genes in AD and psoriasis (PS) versus normal skin, by arrays. Overall many more genes were upregulated and downregulat

    Differentially and commonly upregulated (red) and downregulated (green) regulated genes in AD and psoriasis (PS) versus normal skin, by arrays. Overall many more genes were upregulated and downregulated in psoriasis than in AD, with 322 and 441 genes commonly upregulated and downregulated, respectively, in both diseases. Criteria of FC ≥3 and FDR <0.05 applied.

  • Image Result
    Genomic expression similarities between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated genes (A) and downregulated genes (B) in both AD and PS compared

    Genomic expression similarities between AD and psoriasis (PS) compared with normal skin. Heat maps representing the top 25 upregulated genes (A) and downregulated genes (B) in both AD and PS compared with normal skin. FC values represent AD and PS versus normal skin. All FDR values were highly significant (P < .001).

  • Image Result
    Genomic expression differences of TH1, TH2, and TH17 immune pathways in AD, psoriasis (PS), and normal skin by microarray (A) and real-time PCR (B). Whereas PS deviates toward TH1/TH17, AD polarizes t

    Genomic expression differences of TH1, TH2, and TH17 immune pathways in AD, psoriasis (PS), and normal skin by microarray (A) and real-time PCR (B). Whereas PS deviates toward TH1/TH17, AD polarizes toward TH2. C, “Immune-signature” class prediction classifying these diseases. Horizontal bars represent centroids for AD and PS groups (upregulated genes (vs normal) on the right, downregulated on the left). Norm, Normal.

  • Image Result
    Genomic expression differences of TH1, TH2, and TH17 immune pathways in AD, psoriasis (PS), and normal skin by microarray (A) and real-time PCR (B). Whereas PS deviates toward TH1/TH17, AD polarizes t

    Genomic expression differences of TH1, TH2, and TH17 immune pathways in AD, psoriasis (PS), and normal skin by microarray (A) and real-time PCR (B). Whereas PS deviates toward TH1/TH17, AD polarizes toward TH2. C, “Immune-signature” class prediction classifying these diseases. Horizontal bars represent centroids for AD and PS groups (upregulated genes (vs normal) on the right, downregulated on the left). Norm, Normal.

 Supported by grant number 5UL1RR024143-02 from the National Center for Research Resources, a component of the National Institutes of Health, and the National Institutes of Health Roadmap for Medical Research.

 Disclosure of potential conflict of interest: J. G. Krueger has received research support from Centocor, Amgen, and Wyeth. The rest of the authors have declared that they have no conflict of interest.

PII: S0091-6749(09)01432-8

doi: 10.1016/j.jaci.2009.09.031

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1235-1244.e58 , December 2009